572.16
Regeneron Pharmaceuticals Inc (REGN) 最新ニュース
Is Regeneron at a Turning Point After 43% Drop and FDA Eye Drug Approval News? - simplywall.st
Analysts Are Bullish on Top Healthcare Stocks: Regeneron (REGN), Sysmex (SSMXF) - The Globe and Mail
Can you recover from losses in Regeneron Pharmaceuticals Inc.July 2025 Macro Moves & High Conviction Buy Zone Alerts - newser.com
Can Regeneron Pharmaceuticals Inc. (RGO) stock deliver consistent EPS growthPortfolio Risk Summary & Verified Entry Point Signals - newser.com
Leo Wealth LLC Boosts Stock Position in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Will Regeneron Pharmaceuticals Inc. continue its uptrendJuly 2025 News Drivers & Proven Capital Preservation Tips - newser.com
Regeneron Pharmaceuticals Inc. stock daily chart insights2025 Institutional Moves & Verified Entry Point Signals - newser.com
Forecasting Regeneron Pharmaceuticals Inc. price range with options dataEntry Point & Daily Oversold Bounce Ideas - newser.com
How Is Regeneron’s Stock Performance Compared to Other Pharma Stocks? - MSN
Libtayo’s CSCC Label Expansion Broadens Practitioner Base - insights.citeline.com
Regeneron's Libtayo Gains FDA Approval To Reduce Recurrence Risk In Skin Cancer Patients - Benzinga
Retail Buzz Builds Around Regeneron After FDA Clears Libtayo For High-Risk Skin Cancer; Traders Eye ‘Buying Opportunity’ - Stocktwits
Regeneron, needing a turnaround, gains new use for cancer drug - BioPharma Dive
Regeneron Gets FDA Nod for Label Expansion of Oncology Drug Libtayo - The Globe and Mail
New FDA approval for Libtayo - The Pharma Letter
8,976 Shares in Regeneron Pharmaceuticals, Inc. $REGN Acquired by Bar Harbor Wealth Management - MarketBeat
FDA approves Regeneron’s Libtayo for high-risk CSCC post-surgery - Yahoo
Bispecific Antibodies MarketGlobal Forecast 2025-2032, Profiles of Key PlayersF. Hoffmann-La Roche, Amgen, Janssen Biotech, Pfizer, AbbVie, Regeneron, MacroGenics, AstraZeneca, Merck, and Genmab - GlobeNewswire
Regeneron Pharmaceuticals, Inc. $REGN Shares Sold by QRG Capital Management Inc. - MarketBeat
Regeneron Pharmaceuticals (REGN) Stock: Dips Despite FDA’s Breakthrough Approval for Libtayo in High-Risk CSCC - parameter.io
US FDA expands use of Regeneron’s Libtayo as add-on treatment for skin cancer - 104.1 WIKY
Libtayo approved in the U.S. for adjuvant treatment of cutaneous squamous cell carcinoma - MarketScreener
US FDA expands use of Regeneron's Libtayo as add-on treatment for skin cancer - Reuters
Regeneron (REGN) Gains FDA Approval for Cancer Therapy Libtayo - GuruFocus
FDA Approves Regeneron's Libtayo for High-Risk Skin Cancer Treat - GuruFocus
FDA Approves Regeneron's (REGN) Libtayo for High-Risk Skin Cance - GuruFocus
Regeneron Pharmaceuticals Announces FDA Approval of Libtayo® as Adjuvant Treatment for High-Risk Cutaneous Squamous Cell Carcinoma - Quiver Quantitative
Regeneron stock rises after FDA approves Libtayo for high-risk skin cancer - Investing.com
68% Risk Reduction: Regeneron's Libtayo Approved as First Adjuvant Immunotherapy for CSCC - Stock Titan
Regeneron Pharma stock price target raised by RBC to $704 on Dupixent growth By Investing.com - Investing.com Nigeria
Regeneron Pharma stock price target raised by RBC to $704 on Dupixent growth - Investing.com Nigeria
RBC Raises Price Target on Regeneron Pharmaceuticals to $704 From $695, Keeps Sector Perform Rating - MarketScreener
Dohj LLC Boosts Holdings in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
KLP Kapitalforvaltning AS Cuts Stake in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Regeneron Pharmaceuticals, Inc. $REGN Shares Purchased by Valeo Financial Advisors LLC - MarketBeat
Regeneron Pharmaceuticals Experiences Revision in Stock Evaluation Amid Market Challenges - Markets Mojo
Regeneron Pharmaceuticals, Inc. $REGN Shares Sold by Ameliora Wealth Management Ltd. - MarketBeat
Regeneron (REGN): Reevaluating Valuation Following Breakthrough Trial Results and Evkeeza’s FDA Pediatric Approval - Yahoo Finance
Regeneron Pharmaceuticals, Inc. $REGN Shares Sold by Slow Capital Inc. - MarketBeat
Regeneron Pharmaceuticals to Acquire 23andMe for $256M - MSN
Galderma Punches Above Its Weight Against Dermatology Goliaths - insights.citeline.com
Regeneron Pharmaceuticals (REGN): Valuation in Focus Following Breakthrough Pipeline Results and Expanded Drug Approvals - simplywall.st
Strategies to average down on Regeneron Pharmaceuticals Inc.2025 Top Gainers & Smart Investment Allocation Tips - newser.com
Regeneron (REGN) Projects $83 Million R&D Charge in Q3 2025 - GuruFocus
Regeneron expects $83 million IPR&D charge in third quarter 2025 results - Investing.com
Top chart patterns to watch in Regeneron Pharmaceuticals Inc.Earnings Miss & Advanced Technical Signal Analysis - newser.com
Can trapped investors hope for a rebound in Regeneron Pharmaceuticals Inc.Earnings Summary Report & Weekly High Potential Alerts - newser.com
Is Regeneron Pharmaceuticals Inc. stock resilient to inflationQuarterly Market Review & Verified Technical Trade Signals - newser.com
111 Capital Makes New $517,000 Investment in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
J. Safra Sarasin Holding AG Sells 438 Shares of Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Janney Montgomery Scott LLC Has $6.61 Million Stock Holdings in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Published on: 2025-10-06 01:04:19 - newser.com
Marietta Wealth Management LLC Has $6.01 Million Stake in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Why pension funds invest in Regeneron Pharmaceuticals Inc. (RGO) stock2025 Support & Resistance & Daily Risk Controlled Trade Plans - newser.com
Applying Elliott Wave Theory to Regeneron Pharmaceuticals Inc.Weekly Stock Recap & Accurate Buy Signal Alerts - newser.com
Why millennials buy Regeneron Pharmaceuticals Inc. (RGO) stockRisk Management & Expert Approved Momentum Trade Ideas - newser.com
Why Regeneron (REGN) Is Up 6.4% After FDA Expansion and Positive Late-Stage Trial Results - simplywall.st
Mirae Asset Global Investments Co. Ltd. Grows Stake in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Robeco Institutional Asset Management B.V. Trims Stock Position in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Truist Financial Corp Decreases Stock Holdings in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Regeneron Pharmaceuticals catalysts could drive stock higher: analysts - Proactive financial news
大文字化:
|
ボリューム (24 時間):